Publications by authors named "Wensong Ge"

Article Synopsis
  • Mitochondrial dysfunction plays a significant role in inflammatory bowel disease (IBD), yet there are limited reports on targeted treatments that address this issue.
  • Researchers developed a novel oral treatment called HA-Cr nanogel, which combines selenium and creatine to enhance mitochondrial energy metabolism and eliminate reactive oxygen species (ROS) specifically at inflammation sites.
  • The HA-Cr nanogel showed promising results in improving IBD symptoms by restoring mitochondrial function, reducing inflammatory macrophage activity, repairing gut mucosa, and supporting microbial health, suggesting a new avenue for IBD treatment.
View Article and Find Full Text PDF

The production of reactive oxygen species (ROS) is susceptible to external excitation or insufficient supply of related participants (, hydrogen peroxide (HO) and sensitizer), liming ROS-driven tumor treatment. Additionally, the lysosomal retention effect severely hinders the utilization of ROS-based nanosystems and severely restricted the therapeutic effect of tumors. Therefore, first reported herein an intelligent nanocatalyst, TCPP-Cu@MnO ((Mn)(Mn)(Mn)O), and proposed a programmed ROS amplification strategy to treat tumors.

View Article and Find Full Text PDF

Background And Study Aims: Currently, an increasing amount of experimental data is available on newly discovered biomarkers in inflammatory bowel diseases (IBD), but the role of these biomarkers is often questionable due to their limited sensitivity. Therefore, this study aimed to build a diagnostic tool incorporating a panel of serum biomarkers into a computational algorithm to identify patients with IBD and differentiate those with Crohn's disease (CD) from those with ulcerative colitis (UC).

Patients And Methods: We studied sera from 192 CD patients, 118 UC patients, 60 non-IBD controls and 60 healthy controls.

View Article and Find Full Text PDF
Article Synopsis
  • * Data was collected from over 1,000 patients with a follow-up period of about 5.3 years, indicating high usage of IBD treatments but a lower rate of surgeries compared to Western counterparts.
  • * Findings suggest that while treatment exposure is similar, the natural progression of UC in China differs from that in Western countries, highlighting the need for careful monitoring and further research to confirm these results due to potential biases in the study design.
View Article and Find Full Text PDF

Background: Ustekinumab (UST) is approved as an effective therapy for Crohn's disease (CD) in adults. Off-label use is increasing in the pediatric population, more data on safety and efficacy in pediatric patients with CD is urgently needed.

Aims: This study aimed to evaluate the clinical efficacy and safety of UST in children and adolescents with Crohn's disease.

View Article and Find Full Text PDF

Background And Objective: The dynamic assessment of disease activity during the follow-up of patients with Crohn's disease (CD) remains a significant challenge. In this study, we aimed to identify the role of dynamic contrast-enhanced ultrasound (DCE-US) in the evaluation of activity of CD.

Methods: In the retrospective study, patients diagnosed with CD in our hospital were included.

View Article and Find Full Text PDF

Background: The protective efficacy of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination against the new-onset gastrointestinal (GI) symptoms following COVID-19 infection is critical among patients with inflammatory bowel disease (IBD); however, the optimal protective vaccine dose remains unknown. Therefore, this study aimed to clarify whether there is a correlation between SARS-CoV-2 vaccinations and GI symptoms following Omicron infection in patients with IBD.

Methods: We conducted a multicenter cross-sectional study of IBD patients among three tertiary hospitals in eastern China.

View Article and Find Full Text PDF
Article Synopsis
  • * Researchers discovered that a protein called AMBRA1 is found in higher amounts in inflamed intestines and helps to increase inflammation.
  • * By removing AMBRA1, they found less inflammation and better results when treating with infliximab, showing that targeting AMBRA1 could help people with difficult cases of IBD.
View Article and Find Full Text PDF

Background And Study Aims: Monitoring disease activity in ulcerative colitis (UC) is critical in preventing long-term complications. This study aims to develop a scoring system using non-invasive indicators to predict endoscopic activities for ulcerative colitis (UC) patients.

Patients And Methods: All enrolled patients with UC admitted to Shanghai Xinhua Hospital between June 2017 and January 2021 were enrolled, and their clinical data were retrospectively collected and a number of serological biomarkers concentrations were analyzed.

View Article and Find Full Text PDF

Currently, commercialized infliximab (IFX) has rapidly propelled the clinical treatment of IBD, however, its inherent attributes, such as off-target effects and rapid metabolism, severely limit practical applications. Moreover, high doses injection of IFX can result in IBD treatment failure, which may induce other side effects. In this study, an colon microenvironment-responsive hydrogel (AL/HA hydrogel), consisting of acid-resistant sodium alginate and colon-degraded and targeted hyaluronic acid, was constructed by simple Ca/Zn cross-linking.

View Article and Find Full Text PDF

Background And Aims: The concurrence of nonalcoholic steatohepatitis (NASH) and ulcerative colitis (UC) is increasingly seen in clinical practice, but the underlying mechanisms remain unclear. This study aimed to develop a mouse model of the phenomenon by combining high-fat high-cholesterol diet (HFHCD)-induced NASH and dextran sulfate sodium (DSS)-induced UC, that would support mechanistic studies.

Methods: Male C57BL/6 mice were randomly assigned to two groups receiving either a chow diet or HFHCD for 12 weeks of NASH modeling.

View Article and Find Full Text PDF

Background: Severe lower gastrointestinal bleeding (SLGIB) is a rare complication of Crohn's disease (CD). The treatment of these patients is a clinical challenge. Monoclonal anti-TNFα antibody (IFX) can induce relatively fast mucosal healing.

View Article and Find Full Text PDF

The development of strain sensors with high sensitivity and stretchability is essential for health monitoring, electronic skin, wearable devices, and human-computer interactions. However, sensors that combine high sensitivity and ultra-wide detection generally require complex preparation processes. Here, a novel flexible strain sensor with high sensitivity and transparency was proposed by filling a multiwalled carbon nanotube (MWCNT) solution into polydimethylsiloxane (PDMS) channel films fabricated via an electric field-driven (EFD) 3D printing and molding hybrid process.

View Article and Find Full Text PDF

Background: Inflammatory bowel disease (IBD) is a self-destructive intestinal disease whose etiology is unclear but complex and the effective treatment is deficient. Increasing evidences have indicated that immune dysfunction and epithelial-mesenchymal transition (EMT)-related intestinal mucosal barrier impaired hold critical position in the pathogenesis of IBD. Artemisinin (ART) is a sesquiterpenoid compound extracted from Chinese herbal medicine which has good immunomodulatory effects.

View Article and Find Full Text PDF

Background And Aims: There is evidence for a disturbed necroptosis function in many inflammatory diseases, but its role in inflammatory bowel diseases [IBD] and the underlying mechanisms are unclear. Here, we studied the functional significance and molecular mechanisms of ABIN3, a ubiquitin-binding protein, in regulating the ubiquitination and activation of necroptosis in IBD.

Methods: The expression of necroptosis hallmarks and ABIN3 were assessed in inflamed samples of IBD patients, dextran sodium sulphate [DSS]-induced colitis models, and azoxymethane [AOM]/DSS models in mice.

View Article and Find Full Text PDF

Background And Aims: Defective autophagy has been proposed as an important event in a growing number of autoimmune and inflammatory diseases such as rheumatoid arthritis and lupus. However, the precise role of mechanistic target of rapamycin (mTOR)-dependent autophagy and its underlying regulatory mechanisms in the intestinal epithelium in response to inflammation and oxidative stress remain poorly understood.

Methods: The levels of p-mTOR, LC3B, p62 and autophagy in mice and LPS-treated cells were examined by immunoblotting, immunohistochemistry, confocal microscopy and transmission electron microscopy (TEM).

View Article and Find Full Text PDF

Regulatory interleukin-10 (IL-10)-producing B cells (B10 cells) play a critical role in preventing and curing autoimmune diseases in experimental mouse models. However, the precise cellular and molecular mechanisms of action of B10 cells in humans, especially in patients with Crohn's disease (CD), remain to be determined. miR-155 regulates many physiological and pathological conditions, including inflammation such as that in CD.

View Article and Find Full Text PDF

Ulcerative colitis (UC) pathogenesis is related to imbalance of immune responses, and the equilibrium between inflammatory T cells and Foxp3 regulatory T cells (Tregs) plays an important role in the intestinal homeostasis. Protein arginine methyltransferases (PRMTs) regulate chromatin remodeling and gene expression. Here, we investigated whether inhibition of PRMTs affects colitis pathogenesis in mice and inflammatory bowel disease patients and further explored the underlying mechanisms.

View Article and Find Full Text PDF

Tight junction dysfunction plays a vital role in some chronic inflammatory diseases. Pro-inflammatory cytokines, especially tumor necrosis factor alpha (TNF-α), act as important factors in intestinal epithelial tight junction dysfunction during inflammatory conditions. Autophagy has also been shown to be crucial in tight junction function and claudin-2 expression, but whether autophagy has an effect on the change of claudin-2 expression and tight junction function induced by TNF-α is still unknown.

View Article and Find Full Text PDF

High‑mobility‑group‑box chromosomal protein 1 (HMGB1) is a ubiquitous and abundant nuclear protein in eukaryotic cells. Nuclear HMGB1 serves an important role in maintaining nuclear stability under stress. However, extracellular HMGB1 exerts actions, which are distinctly different compared with these intracellular functions.

View Article and Find Full Text PDF

Aim: To evaluate the efficacy and safety of integrin antagonists, including natalizumab and vedolizumab, in Crohn's disease (CD).

Methods: We carried out a literature search in PubMed, MEDLINE, EMBASE and the Cochrane Library to screen for citations from January 1990 to August 2014. Data analysis was performed using Review Manager version 5.

View Article and Find Full Text PDF

This study was undertaken to evaluate the efficacy of infliximab (IFX) in treatment of Crohn's disease (CD) patients. 106 CD patients were undergoing treatment with IFX from five hospitals in Shanghai, China. Clinical remission to IFX induction therapy was defined as Crohn's disease activity index (CDAI) < 150.

View Article and Find Full Text PDF

Background & Aims: It has recently been reported that thymosin beta-4 (Tβ4) has anti-fibrogenic effects in human hepatic stellate cells (HSCs) in vitro, but the mechanisms underlying these effects remain unclear. The aim of this study was to investigate the roles of Tβ4 in the proliferation, migration, and activation of HSCs.

Methods: Enzyme-linked immunosorbent assays (ELISA), immunohistochemistry, and western blot assays were utilized to determine the expression levels of Tβ4 in serum, liver tissues, and LX-2 cells.

View Article and Find Full Text PDF

β-catenin, a core component of Wnt/β-catenin signaling, has been shown to be an important regulator of cellular proliferation and differentiation. Abnormal activation of Wnt/β-catenin signaling promotes tissue fibrogenesis. In the present study, the role of β-catenin during liver fibrogenesis was analyzed and the functional effects of β-catenin gene silencing in hepatic stellate cells (HSCs) using small interfering (si)RNA were investigated.

View Article and Find Full Text PDF

Intestinal fibrosis is one of the major serious complications of Crohn's disease (CD). However, there are no effective antifibrotic drugs to treat intestinal fibrosis in CD. Therefore, it is important to understand the pathogenesis of fibrosis in CD.

View Article and Find Full Text PDF